Drug Discovery World

MARCH 29, 2023

The commission is looking to put more pressure on pharma companies to report such shortages, and to offer a drug’s marketing authorisation to another company before withdrawing it from the market. She also does not believe that the problems with Europe’s medicines can be solved with regulation.

Clinical Trials 130

Clinical Trials Biosimilars Pharma Companies Production 130

Drug Discovery World

FEBRUARY 20, 2024

An obvious opportunity could be to demonstrate the interoperability of BlockSent with EDC systems that are commonly used in clinical trials by pharma companies and to combine BlockSent with a blockchain network offering a smart contract 15 capability. Ther Innov Regul Sci. 2020; 54: 1123-1133. Mazières D and Shasha D.

Clinical Trials 130

Clinical Trials Pharma Companies Trials Compliance 130

Drug Discovery World

FEBRUARY 20, 2024

An obvious opportunity could be to demonstrate the interoperability of BlockSent with EDC systems that are commonly used in clinical trials by pharma companies and to combine BlockSent with a blockchain network offering a smart contract 15 capability. Ther Innov Regul Sci. 2020; 54: 1123-1133. Mazières D and Shasha D.

Clinical Trials 130

Clinical Trials Pharma Companies Trials Compliance 130